Literature DB >> 17525875

Ketamine and the potential role for rapid-acting antidepressant medications.

John H Krystal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17525875     DOI： 2007/15/smw-11932

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN： 0036-7672            Impact factor:   2.193


× No keyword cloud information.
  11 in total

1.  mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.

Authors:  Nanxin Li; Boyoung Lee; Rong-Jian Liu; Mounira Banasr; Jason M Dwyer; Masaaki Iwata; Xiao-Yuan Li; George Aghajanian; Ronald S Duman
Journal:  Science       Date:  2010-08-20       Impact factor: 47.728

2.  Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept trial.

Authors:  Scott A Irwin; Alana Iglewicz; Richard A Nelesen; Jessica Y Lo; Connie H Carr; Sheilani D Romero; Linda S Lloyd
Journal:  J Palliat Med       Date:  2013-06-27       Impact factor: 2.947

Review 3.  Modeling treatment-resistant depression.

Authors:  Benjamin Adam Samuels; Eduardo David Leonardo; Reto Gadient; Amanda Williams; Jin Zhou; Denis J David; Alain Michel Gardier; Erik H F Wong; René Hen
Journal:  Neuropharmacology       Date:  2011-02-26       Impact factor: 5.250

Review 4.  Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.

Authors:  John H Krystal; Sanjay J Mathew; D Cyril D'Souza; Amir Garakani; Handan Gunduz-Bruce; Dennis S Charney
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

Review 5.  Glutamatergic drive of the dorsal raphe nucleus.

Authors:  Mariano Soiza-Reilly; Kathryn G Commons
Journal:  J Chem Neuroanat       Date:  2011-04-27       Impact factor: 3.052

6.  Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.

Authors:  Nanxin Li; Rong-Jian Liu; Jason M Dwyer; Mounira Banasr; Boyoung Lee; Hyeon Son; Xiao-Yuan Li; George Aghajanian; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2011-02-03       Impact factor: 13.382

7.  Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats.

Authors:  Y Tizabi; B H Bhatti; K F Manaye; J R Das; L Akinfiresoye
Journal:  Neuroscience       Date:  2012-04-19       Impact factor: 3.590

8.  Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases.

Authors:  Alana Iglewicz; Katherine Morrison; Richard A Nelesen; Tingting Zhan; Boris Iglewicz; Nathan Fairman; Jeremy M Hirst; Scott A Irwin
Journal:  Psychosomatics       Date:  2014-06-05       Impact factor: 2.386

9.  Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.

Authors:  Scott A Irwin; Alana Iglewicz
Journal:  J Palliat Med       Date:  2010-07       Impact factor: 2.947

10.  Rapid Antidepressant Activity of Ethanol Extract of Gardenia jasminoides Ellis Is Associated with Upregulation of BDNF Expression in the Hippocampus.

Authors:  Hailou Zhang; Wenda Xue; Runjie Wu; Tong Gong; Weiwei Tao; Xin Zhou; Jingjing Jiang; Ying Zhang; Nan Zhang; Yi Cui; Chang Chen; Gang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-24       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.